Jane Street’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$241K Buy
+38,336
New +$274K ﹤0.01% 9671
2026
Q1
– Sell
-47,431
Closed -$272K – 11540
2025
Q4
$258K Buy
47,431
+14,327
+43% +$85.1K ﹤0.01% 9160
2025
Q3
$205K Buy
+33,104
New +$216K ﹤0.01% 9646
2024
Q4
– Sell
-24,958
Closed -$222K – 9359
2024
Q3
$222K Sell
24,958
-39,583
-61% -$339K ﹤0.01% 8502
2024
Q2
$488K Buy
64,541
+43,519
+207% +$319K ﹤0.01% 7054
2024
Q1
$165K Sell
21,022
-7,765
-27% -$64.4K ﹤0.01% 8285
2023
Q4
$255K Buy
+28,787
New +$244K ﹤0.01% 7867

Other funds holding AURA

Jane Street's AURA Position: Q3 2026 in Review

Jane Street opened a new position in Aura Biosciences (AURA) in Q3 2026: 38,336 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #9671 among its holdings. This is a return to the name: Jane Street previously reported a position in AURA as recently as Q4 2025.

Jane Street first reported a position in AURA in Q4 2023 and has held it in 7 quarters since. The position peaked at $488K in Q2 2024. 154 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • Jane Street held 38,336 shares of Aura Biosciences worth $241K as of Q3 2026.
  • Aura Biosciences was a new Jane Street position in Q3 2026.
  • Aura Biosciences made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9671 holding.
  • Jane Street first reported a position in Aura Biosciences in Q4 2023 and has held it in 7 quarters since.
  • Jane Street's Aura Biosciences position peaked at $488K in Q2 2024.
  • 154 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.